Morningstar

Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy ...

Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting – ...

Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome

Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...
MIT Technology Review

An easier-to-use technique for storing data in DNA is inspired by our cells

Encoding information in DNA has long seemed like a promising way to secure data for the long term, but so far it has required an expert touch. It turns out that you don’t need to be a scientist to ...
TechCrunch

Streamdal wants to bring greater visibility to streaming data architectures

The rise of streaming architectures — frameworks of software components built to ingest and process large volumes of data from multiple sources — is driving the demand for better reliability and ...
Morningstar

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Publication includes complete data for all participants (n=39) up to week 72, further demonstrating durable and tolerable expression of DMAbs Effective target binding and confirmed functional activity ...